Mesenchymal Stem/Stromal Cells (MSCs) hold great promise as a cell-based therapy in the treatment of immune disorders and in regenerative medicine. Despite decades of extensive research in elucidating the role of MSCs in maintenance of the hematopoietic niche and in deciphering MSCs heterogeneity, it is the latter that has been posing a ...

See the rest here:

Mesenchymal Stem/Stromal Cells An update | SpringerLink

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh